We serve Chemical Name:Ethyl 2,4,5-trifluorobenzoate CAS:351354-41-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl 2,4,5-trifluorobenzoate
CAS.NO:351354-41-1
Synonyms:Benzoic acid, 2,4,5-trifluoro-, ethyl ester;PC7793;2,4,5-Trifluorobenzoic acid ethyl ester;Ethyl 2,4,5-trifluorobenzoate
Molecular Formula:C9H7F3O2
Molecular Weight:204.146
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:230.4±40.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.457
PSA:26.30000
Exact Mass:204.039810
LogP:2.83
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzoic acid, 2,4,5-trifluoro-, ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 2,4,5-trifluorobenzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzoic acid, 2,4,5-trifluoro-, ethyl ester Use and application,PC7793 technical grade,usp/ep/jp grade.
Related News: Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. 3-cyclohexyl-1-((S)-2-(5-((3,5-dimethoxyphenoxy)methyl)-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-2,2-difluoro-3-hydroxypropan-1-one manufacturers GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. diethyl (periodoterephthaloyl)diprolinate suppliers The development of various enabling technologies has been critical in expanding the potential of biocatalytic processing, as well as in promoting its uptake across the pharmaceutical industry. 7-hydroxy-6-methoxy-3H-2-benzofuran-1-one vendor & factory Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. ,GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said.
